Sage Rhino Capital LLC Bristol Myers Squibb CO Transaction History

Sage Rhino Capital LLC

$446 Million
Q4 2024

A detailed history of Sage Rhino Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sage Rhino Capital LLC holds 4,278 shares of BMY stock, worth $256,123. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,278

Previous 4,222 1.33%

Holding current value

$256,123

Previous $218,000 10.55%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$51.92 - $59.94 $2,907 - $3,356	56 Added 1.33%	4,278 $241,000
Q3 2024 Nov 01, 2024	BUY	$39.66 - $51.75 $167,444 - $218,488	4,222 New	4,222 $218,000
Q1 2024 Apr 26, 2024	SELL	$47.98 - $54.4 $4,126 - $4,678	-86 Reduced 2.17%	3,884 $210,000
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $9,065 - $10,817	-187 Reduced 4.5%	3,970 $203,000
Q3 2023 Oct 26, 2023	SELL	$57.89 - $64.73 $5,962 - $6,667	-103 Reduced 2.42%	4,157 $241,000
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $18,603 - $20,656	-292 Reduced 6.41%	4,260 $272,000
Q1 2023 Apr 20, 2023	BUY	$65.71 - $74.53 $15,704 - $17,812	239 Added 5.54%	4,552 $315,000
Q4 2022 Jan 31, 2023	BUY	$68.48 - $81.09 $5,067 - $6,000	74 Added 1.75%	4,313 $310,000
Q3 2022 Oct 24, 2022	SELL	$0.13 - $76.84 $11 - $6,608	-86 Reduced 1.99%	4,239 $301,000
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $5,228 - $5,758	72 Added 1.69%	4,325 $333,000
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $676 - $810	-11 Reduced 0.26%	4,253 $311,000
Q4 2021 Feb 04, 2022	SELL	$53.63 - $62.52 $197,465 - $230,198	-3,682 Reduced 46.34%	4,264 $266,000
Q3 2021 Oct 18, 2021	BUY	$59.17 - $69.31 $591 - $693	10 Added 0.13%	7,946 $470,000
Q2 2021 Jul 27, 2021	SELL	$61.91 - $67.42 $138,554 - $150,885	-2,238 Reduced 22.0%	7,936 $530,000
Q1 2021 May 04, 2021	BUY	$59.34 - $66.74 $1,483 - $1,668	25 Added 0.25%	10,174 $642,000
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $5,138 - $5,823	-89 Reduced 0.87%	10,149 $630,000
Q3 2020 Nov 05, 2020	SELL	$57.43 - $63.64 $16,654 - $18,455	-290 Reduced 2.75%	10,238 $617,000
Q2 2020 Jul 30, 2020	BUY	$54.82 - $64.09 $11,457 - $13,394	209 Added 2.03%	10,528 $619,000
Q1 2020 Apr 29, 2020	BUY	$46.4 - $67.43 $14,059 - $20,431	303 Added 3.03%	10,319 $575,000
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $242,654 - $316,520	4,931 Added 96.97%	10,016 $653,000
Q3 2019 Oct 25, 2019	BUY	$42.77 - $50.71 $13,857 - $16,430	324 Added 6.81%	5,085 $258,000
Q2 2019 Aug 20, 2019	SELL	$44.62 - $49.34 $2,944 - $3,256	-66 Reduced 1.37%	4,761 $216,000
Q1 2019 Apr 18, 2019	BUY	$45.12 - $53.8 $217,794 - $259,692	4,827 New	4,827 $230,000

Others Institutions Holding BMY

# of Institutions

2,760

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $127B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Bristol Myers Squibb CO Transaction History